We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Tim Heffernan Tim Heffernan is a writer who covers air and water quality and ...
BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, ...
Orasure Technologies ( (OSUR)) has issued an update. On January 5, 2026, OraSure Technologies reported that at the end of 2025 it submitted two applications to the U.S. Food and Drug Administration ...
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at-home tests for sexually transmitted infections (STIs), aiming to expand ...
BETHLEHEM, Pa. - OraSure Technologies, Inc. (NASDAQ:OSUR) has submitted two separate applications to the U.S. Food and Drug Administration for clearance of its rapid molecular self-test for Chlamydia ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The maker of kitchen and bath ...
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the OraSure Technologies, Inc. 2025 Third Quarter Earnings Conference Call. Good afternoon, and ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Maria Adelmann Maria Adelmann is a writer covering travel. She once left on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results